4.3 Article

Autoimmune Hepatitis Pathophysiology

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

Autoimmune serology testing in clinical practice: An updated roadmap for the diagnosis of autoimmune hepatitis

George N. Dalekos et al.

Summary: Diagnosis of autoimmune hepatitis (AIH) is challenging due to the lack of specific markers, and a thorough differential diagnosis is necessary. Autoantibodies detection is mandatory for AIH diagnosis and classification. However, real-life circumstances can lead to underestimation and misdiagnosis. Communication between clinicians and laboratory personnel is crucial to ensure accurate testing and interpretation of results.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Review Medicine, General & Internal

Diagnosis and management of autoimmune hepatitis

Luigi Muratori et al.

Summary: Autoimmune hepatitis is an inflammatory liver disease of unknown cause that can progress to cirrhosis and liver failure if not diagnosed and treated in a timely manner. It can present as acute hepatitis, sometimes severe, or be asymptomatic. The disease is more common in women and its incidence and prevalence appear to be increasing globally. The pathogenesis involves an abnormal immune response targeting liver antigens, leading to persistent inflammation. Diagnosis is based on specific autoantibodies, elevated IgG levels, and histological evidence of liver inflammation. Treatment with corticosteroids and immunomodulatory drugs is highly effective, aiming to induce and maintain long-term remission. Liver fibrosis can be reversed and complications prevented. Lifelong maintenance therapy and regular follow-up are often necessary for optimal patient care and quality of life.

BMJ-BRITISH MEDICAL JOURNAL (2023)

Review Immunology

The impact of the gut microbiome on extra-intestinal autoimmune diseases

Eiji Miyauchi et al.

Summary: The prevalence of autoimmune diseases has increased rapidly worldwide. Besides traditional risk factors, alterations in gut microbiota have been identified as important factors influencing autoimmune responses and disease outcome in extra-intestinal autoimmune diseases.

NATURE REVIEWS IMMUNOLOGY (2023)

Article Gastroenterology & Hepatology

Genome-wide meta-analysis identifies susceptibility loci for autoimmune hepatitis type 1

You Li et al.

Summary: The study identifies two novel loci, CD28/CTLA4/ICOS and SYNPR, that are significantly associated with autoimmune hepatitis (AIH) type 1. Four other loci also show suggestive association signals with AIH. These findings highlight the importance of costimulatory signaling and neuro-immune interaction in the pathogenesis of AIH.

HEPATOLOGY (2022)

Article Immunology

Pathogenesis of Concanavalin A induced autoimmune hepatitis in mice

Jianheng Hao et al.

Summary: This article investigates the pathogenesis of Con A-induced liver injury in mice, discusses the role of non-coding RNA and the signaling pathways involved in this model, and also mentions the advantages and limitations of this model, providing research directions for future studies on the treatment of AIH.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Article Microbiology

Tet2 deficiency drives liver microbiome dysbiosis triggering Tc1 cell autoimmune hepatitis

Surya P. Pandey et al.

Summary: This study reveals that lack of hematopoietic Tet methylcytosine dioxygenase 2 (Tet2) contributes to the development of autoimmune hepatitis (AIH). AIH is associated with interferon-gamma and aryl hydrocarbon receptor (AhR) signaling pathways, as well as the presence of AhR ligand-producing pathobionts in the liver. Furthermore, the study demonstrates that the AhR ligand indole-3aldehyde (I3A) released by Lactobacillus reuteri can trigger AIH-like pathology.

CELL HOST & MICROBE (2022)

Article Gastroenterology & Hepatology

Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology

Ansgar W. Lohse et al.

Summary: This study aimed to establish histological diagnostic criteria for autoimmune hepatitis (AIH), which are applicable to patients with both acute and chronic presentations, and to more accurately reflect the current understanding of liver pathology in AIH.

LIVER INTERNATIONAL (2022)

Article Cell Biology

Methyl butyrate attenuates concanavalin A-induced autoimmune hepatitis by inhibiting Th1-cell activation and homing to the liver

Jingshu Yang et al.

Summary: This study found that methyl butyrate can alleviate Con A-induced hepatitis by inhibiting the activation and migration of Th1 cells in the liver, improving liver function and reducing the expression of inflammatory cytokines.

CELLULAR IMMUNOLOGY (2022)

Review Immunology

HLA, gut microbiome and hepatic autoimmunity

Benedetta Terziroli Beretta-Piccoli et al.

Summary: Genetic susceptibility to autoimmune liver diseases is mainly determined by polymorphisms of genes encoding human leukocyte antigens (HLA). Different HLA genotypes are associated with different types of autoimmune liver diseases. In addition, dysbiosis and increased gut permeability may play a crucial role in the pathogenesis of autoimmune liver diseases.

FRONTIERS IN IMMUNOLOGY (2022)

Review Immunology

Type 2 autoimmune hepatitis: Genetic susceptibility

Pascal Lapierre et al.

Summary: There are two types of autoimmune hepatitis (AIH): AIH-1, characterized by anti-nuclear and/or anti-smooth muscle autoantibodies, and AIH-2, associated with anti-Liver kidney microsome and/or anti-Liver Cytosol antibodies. The autoantigens targeted by AIH-2 autoantibodies are specific to liver cells. AIH-2 has distinct clinical features, such as younger age at diagnosis, fulminant hepatitis in very young patients, higher prevalence in children, and association with extrahepatic T cell-mediated autoimmune diseases.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Exploration the significance of Tfh and related molecules on C57BL/6 mice model of experimental autoimmune hepatitis

Liang Ma et al.

Summary: The autoimmune hepatitis model of C57BL/6 mice was successfully established in this study, and the expression and significance of T follicular helper (Tfh) cells, T follicular regulatory (Tfr) cells, effector B cells and other indicators were examined. The experimental autoimmune hepatitis model exhibited similar pathological features to the chronic and progressive pathogenesis of autoimmune hepatitis patients.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2021)

Article Gastroenterology & Hepatology

Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis

Marta Vuerich et al.

Summary: In patients with autoimmune hepatitis, dysfunction of the aryl hydrocarbon receptor pathway, resulting from aberrant inhibition or non-canonical activation, impairs Treg- and Th17 cell-induced upregulation of CD39, a key ectoenzyme for immuno-regulation. Blockade of excessive inhibition or non-canonical activation of the aryl hydrocarbon receptor pathway might represent a novel therapeutic strategy to control inflammation while restoring immune balance in autoimmune hepatitis.

JOURNAL OF HEPATOLOGY (2021)

Review Biochemistry & Molecular Biology

Pathogenesis of Autoimmune Hepatitis-Cellular and Molecular Mechanisms

Claudia Sirbe et al.

Summary: Pediatric autoimmune liver disorders encompass autoimmune hepatitis, autoimmune sclerosing cholangitis, and de novo AIH after liver transplantation. The pathogenesis involves genetic variations, environmental factors, and epigenetic modifications. Current first-line therapy includes prednisolone plus azathioprine for clinical and biochemical remission induction.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Immunology

IL-17 in the Pathogenesis of Disease: Good Intentions Gone Awry

Saikat Majumder et al.

Summary: The IL-17 family is an evolutionarily old cytokine family with six members, with IL-17A receiving the most attention for its proinflammatory roles in autoimmune diseases. IL-17 is associated with a wide array of diseases, with surprisingly variable pathologies. Recent advances in understanding the roles of IL-17 in health and disease pathogenesis focus on how its beneficial functions can be diverted towards amplification of deleterious pathways driving chronic diseases.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 39 (2021)

Article Immunology

Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis

Laura Elisa Buitrago-Molina et al.

Summary: Autoimmune hepatitis is a chronic inflammatory disease that requires lifelong immunosuppression, with relapses common after therapy discontinuation. Steroid therapy depletes intrahepatic Tregs, but increasing and strengthening these cells may help in immune regulation restoration. Studies have shown that using complexed IL-2/anti-IL-2 can enhance the Treg compartment and restore balance between Tregs and Teffs, offering new hope for AIH patients.

JOURNAL OF AUTOIMMUNITY (2021)

Article Gastroenterology & Hepatology

Human Leukocyte Antigen Profile Predicts Severity of Autoimmune Liver Disease in Children of European Ancestry

Yun Ma et al.

Summary: Unique HLA profiles are observed in each subgroup of juvenile autoimmune liver disease, which may be helpful in predicting responsiveness to treatment and disease course.

HEPATOLOGY (2021)

Article Immunology

Leaky Gut Driven by Dysbiosis Augments Activation and Accumulation of Liver Macrophages via RIP3 Signaling Pathway in Autoimmune Hepatitis

Hongxia Zhang et al.

Summary: The gut-liver axis plays a crucial role in modulating autoimmunity, with intestinal barrier dysfunction leading to increased bacterial translocation and hepatic innate immune response. Therapeutic approaches targeting intestinal microbiota show potential for treating autoimmune hepatitis by dampening inflammatory responses and liver injury.

FRONTIERS IN IMMUNOLOGY (2021)

Article Pharmacology & Pharmacy

Gut microbiome-host interactions in driving environmental pollutant trichloroethene-mediated autoimmunity

Hui Wang et al.

Summary: Trichloroethene (TCE) exposure is associated with the development of autoimmune diseases (ADs), with altered gut microbiome composition being a key factor. Studies on female MRL+/+ mice exposed to TCE revealed distinct changes in bacterial community and increased colonic oxidative stress and inflammatory markers. Fecal microbiota transplantation (FMT) experiments further supported the causal role of microbiome in TCE-mediated autoimmunity.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2021)

Article Gastroenterology & Hepatology

Alterations of gut microbiome in autoimmune hepatitis

Yiran Wei et al.

Article Gastroenterology & Hepatology

A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis

Timur Liwinski et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

Article Immunology

Fecal Microbiomes Distinguish Patients With Autoimmune Hepatitis From Healthy Individuals

Jiamin Lou et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Review Immunology

Pathogens and autoimmune hepatitis

U. Christen et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)

Article Biochemical Research Methods

Expression and Significance of Th17 Cells and Related Factors in Patients with Autoimmune Hepatitis

Jihong An

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2019)

Article Gastroenterology & Hepatology

Association of IL-10 and TGF-beta cytokine gene polymorphisms with autoimmune hepatitis

Azizollah Yousefi et al.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Possible involvement of chemokine C-C receptor 7-programmed cell death-1+ follicular helper T-cell subset in the pathogenesis of autoimmune hepatitis

Naruhiro Kimura et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)

Review Pathology

Cellular and Molecular Mechanisms of Autoimmune Hepatitis

G. J. Webb et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)

Article Pathology

Histologic features of autoimmune hepatitis: a critical appraisal

Ananta Gurung et al.

HUMAN PATHOLOGY (2018)

Article Biotechnology & Applied Microbiology

Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+T cell function

Guo Ai et al.

JOURNAL OF GENE MEDICINE (2018)

Article Gastroenterology & Hepatology

Family occurrence of autoimmune hepatitis: A Danish nationwide registry-based cohort study

Lisbet Gronbaek et al.

JOURNAL OF HEPATOLOGY (2018)

Article Multidisciplinary Sciences

Translocation of a gut pathobiont drives autoimmunity in mice and humans

S. Manfredo Vieira et al.

SCIENCE (2018)

Article Gastroenterology & Hepatology

Autoimmune hepatitis association with single nucleotide polymorphism of interleukin-2, but not interferon-gamma

Azizollah Yousefi et al.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2018)

Article Medicine, General & Internal

Autoimmune hepatitis

Giorgina Mieli-Vergani et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

Article Gastroenterology & Hepatology

Association of Interleukin-6 and Interleukin-1 Family Gene Polymorphisms in Autoimmune Hepatitis

Azizollah Yousefi et al.

ANNALS OF HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Immune Alterations in Patients With Type 1 Autoimmune Hepatitis Persist Upon Standard Immunosuppressive Treatment

Amedee Renand et al.

HEPATOLOGY COMMUNICATIONS (2018)

Article Genetics & Heredity

Association of a single nucleotide polymorphism upstream of ICOS with Japanese autoimmune hepatitis type 1

Takashi Higuchi et al.

JOURNAL OF HUMAN GENETICS (2017)

Article Gastroenterology & Hepatology

Crosstalk between type II NKT cells and T cells leads to spontaneous chronic inflammatory liver disease

Xiufang Weng et al.

JOURNAL OF HEPATOLOGY (2017)

Letter Cell Biology

Increased apoptosis of regulatory T cells in patients with active autoimmune hepatitis

Katharina John et al.

CELL DEATH & DISEASE (2017)

Article Pharmacology & Pharmacy

Immunosuppressive activities of adenosine in cancer

Bertrand Allard et al.

CURRENT OPINION IN PHARMACOLOGY (2016)

Article Gastroenterology & Hepatology

IL4 gene polymorphisms in Iranian patients with autoimmune hepatitis

Azizollah Yousefi et al.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Role of Histopathology in Autoimmune Hepatitis

Dina G. Tiniakos et al.

DIGESTIVE DISEASES (2015)

Article Gastroenterology & Hepatology

Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1

Ynto S. de Boer et al.

GASTROENTEROLOGY (2014)

Article Gastroenterology & Hepatology

Tfh and plasma cells are correlated with hypergammaglobulinaemia in patients with autoimmune hepatitis

Liang Ma et al.

LIVER INTERNATIONAL (2014)

Article Gastroenterology & Hepatology

Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands

Nicole M. F. van Gerven et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2014)

Review Immunology

Gamma delta T-lymphocytes in hepatitis C and chronic liver disease

Neil Rajoriya et al.

FRONTIERS IN IMMUNOLOGY (2014)

Article Gastroenterology & Hepatology

Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells

Matthias Hardtke-Wolenski et al.

HEPATOLOGY (2013)

Article Medicine, Research & Experimental

Medullary thymic epithelial cell depletion leads to autoimmune hepatitis

Anthony J. Bonito et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Review Immunology

Autoimmune manifestations in viral hepatitis

Diego Vergani et al.

SEMINARS IN IMMUNOPATHOLOGY (2013)

Letter Gastroenterology & Hepatology

Regulatory T cell defects in adult autoimmune hepatitis

Silvia Ferri et al.

JOURNAL OF HEPATOLOGY (2012)

Letter Gastroenterology & Hepatology

Regulatory T cells in autoimmune hepatitis

Maria Serena Longhi et al.

JOURNAL OF HEPATOLOGY (2012)

Article Gastroenterology & Hepatology

FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency

Moritz Peiseler et al.

JOURNAL OF HEPATOLOGY (2012)

Editorial Material Gastroenterology & Hepatology

Autoantibodies in autoimmune hepatitis: Antinuclear antibodies (ANA)

Catherine Johanet et al.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2012)

Article Gastroenterology & Hepatology

Simplified criteria for the diagnosis of autoimmune hepatitis

Elke M. Hennes et al.

HEPATOLOGY (2008)

Review Gastroenterology & Hepatology

Autoimmune liver serology: Current diagnostic and clinical challenges

Dimitrios P. Bogdanos et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2008)

Article Immunology

Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis

Maria Serena Longhi et al.

JOURNAL OF IMMUNOLOGY (2006)

Article Pathology

Liver infiltrating mononuclear cells in children with type 1 autoimmune hepatitis

MB De Biasio et al.

JOURNAL OF CLINICAL PATHOLOGY (2006)

Article Gastroenterology & Hepatology

LKM1 autoantibodies in chronic hepatitis C infection:: A case of molecular mimicry?

G Marceau et al.

HEPATOLOGY (2005)

Article Gastroenterology & Hepatology

Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease

MS Longhi et al.

JOURNAL OF HEPATOLOGY (2004)

Article Gastroenterology & Hepatology

Clinicopathological features of acute-onset autoimmune hepatitis

N Okano et al.

HEPATOLOGY RESEARCH (2003)

Review Dermatology

Epitope spreading: protection from pathogens, but propagation of autoimmunity?

AM Powell et al.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2001)